COA KVR-2026-14D354 matches Kovera Labs's public record. So this test doesn't rest on our review alone — the lab confirms it too.
3PW4QEBLabel 12 mg · Lab measured 13.98 mg
117% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 3.5 mg using the measured mass, against 3 mg on the label — 17% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | KVR-2026-14D354 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 27 Jul 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | Kovera Labs's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Tirzepatide from Unknown brand, performed by Kovera Labs on June 23, 2026. Reported purity: 99.582%. Net content: 13.98 mg against 12 mg labeled (117% of label). Tested content exceeds the labeled amount by 17%. Endotoxins: PASS (≤0.5 EU/mL). Heavy metals: Arsenic <0.15, Cadmium <0.05, Lead <0.5, Mercury <0.3 — all Pass. Batch AMC-TZ-12-01. Sample source: shop-provided. Certificate of analysis attached.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion